$6.63 Million is the total value of DC Funds, LP's 3 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HOWL | WEREWOLF THERAPEUTICS INC | $2,657,000 | +10.3% | 589,102 | 0.0% | 40.05% | +20.5% | |
| VACC | VACCITECH PLCads | $2,055,000 | -28.1% | 642,204 | 0.0% | 30.98% | -21.4% | |
| TSCAN THERAPEUTICS INC | $1,922,000 | -3.0% | 630,000 | 0.0% | 28.97% | +6.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VACCITECH PLC | 10 | Q3 2023 | 51.2% |
| WEREWOLF THERAPEUTICS INC | 10 | Q3 2023 | 48.8% |
| TSCAN THERAPEUTICS INC | 9 | Q3 2023 | 33.5% |
View DC Funds, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View DC Funds, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.